Cancer drugs that target gene abnormalities in tumours are one of the major preferences for CROs involved in drug discovery for oncology since the last few decades. Integral Bioscience is a prominent drug discovery CRO dealing with immuno-oncology to fight cancer and other diseases. As a...
